The sudden removal of all 17 CDC Advisory Committee on Immunization Practices members by Health Secretary Robert F. Kennedy Jr. has sparked concern among medical associations citing threats to vaccine science and public health. Concurrently, FDA officials under Commissioner Martin Makary advocate AI integration to accelerate drug approvals. NIH staff have protested politicized research disruptions resulting from funding cuts and policy shifts under the current administration. Meanwhile, significant legislative and pricing debates continue regarding drug cost controls and market regulations.